CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML

Clinical trial NCT03384225 · UNKNOWN

Trial details

NCT number: NCT03384225
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

High Risk Acute Myeloid Leukemia Allogeneic Hematopoeitic Stem Cell Transplantation

Start date: 2016-08-01
Primary completion: 2022-07-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.